Advanced porous plastics for medical & life science applications
A selection of BioVyon components.
BioVyon range have been incorporated into products to achieve more sensitive analysis, better healthcare, improved medical knowledge and faster diagnosis and treatment of diseases.
Porvair Sciences, original manufacturers of porous plastics, will be showcasing its advanced materials for the medical and life science markets at this year’s COMPAMED exhibition in Dusseldorf, Germany.
Visitors will be able to learn how Porvair's BioVyon range of high-performance porous materials have been incorporated into products to achieve more sensitive analysis, better healthcare, improved medical knowledge as well as faster diagnosis and treatment of diseases. Also on display, will be the latest life science and medical products and application solutions from Porvair’s fast-growing Laboratory Division.
Alan Hughes, Advanced Materials account manager at Porvair Sciences commented: "The requirements of porous materials used in devices and systems for medical diagnostics and drug delivery applications are usually far more stringent than those for industrial applications. They need to be contamination-free with very low levels of leachables and with full traceability. Regulatory approval is also an essential prerequisite for many products in these sectors." He added: "Drawing upon the wide range of production equipment in our Wrexham, UK facility, Porvair Sciences not only manufacture the BioVyon materials but can assemble finished products in our cleanroom facility for OEM partners to the high standards demanded by these regulated markets."
BioVyon range of advanced porous plastic materials are being used in applications including drug filtration and purification, catheter vents, bone cement mixing in the operating theatre and nasal spray filters.
Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
.png)
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance